This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification
BMC Cancer Open Access 16 February 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. Genentech to salvage anti-MET antibody with subgroup analysis. Nat Biotechnol 32, 399–400 (2014). https://doi.org/10.1038/nbt0514-399
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0514-399
This article is cited by
-
SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models
Acta Pharmacologica Sinica (2019)
-
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification
BMC Cancer (2016)
-
Prognostic impact and potential interaction of EGFR and c-Met in the progression of esophageal squamous cell carcinoma
Tumor Biology (2016)